August 3 1 , 2 0 1 7 and corresponding period of the previous year, which exceeds 20%. The company would like to clarify as follows. 1. Total revenue is Baht 425.80 million, an increase of Baht 421.95

3Q2016 predominantly from cost advantage from lower major feed material price and the growth in chicken export volume. In addition, the consolidated EBITDA in 3Q2017 was THB 896.18 million, an increase of

working capital in business operation, sourcing raw materials, and increase Company’s production capacity. The interest rate of this loan can be divided into 3 categories as follow; 1. Funded portion at 12

fund as working capital in business operation, sourcing raw materials, and increase Company’s production capacity. The interest rate of this loan can be divided into 3 categories as follow; 1. Funded

producers. Total selling and administrative expenses increased from Baht 133.4 million in 2016 to be Baht 134.8 million in 2017, or 1.06% increased. This was due to the increase in commission expense

increase derived from the domestic sales increasing 10.85 percent. For the year 2018, the proportion of domestic sales was 53 percent of total revenue from sale. In addition, other incomes also increased

-patient and out-paient were increased, also, revenue from out-patient tend to increase. By the way, revenue from medical treatment per patient was in inclined. Cost of Hospital Operations The cost of

increased substantially which can outweigh lower visit number. The increase of revenue per visit was the result of more surgeries operated particularly heart surgeries and minimal invasive surgeries. All

million from as of December 31, 2018. The main reason came from the increase of cash or cash equivalent increasing from the issuance of debentures at the amount of Baht 200 million since March 2019. 2

which lead to increase in the sales volume this quarter. In addition, Company’s revenue was affected by the appreciation of exchange rate of 3% from 32.14 in Quarter 2 2018 to 31.36 in Quarter 2 2019. The